share_log

bluebird bio | 3: Initial statement of beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 3: Initial statement of beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 3:首次持股声明-董事 Cloonan Michael
美股sec公告 ·  06/24 17:16
Moomoo AI 已提取核心信息
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.
Michael Cloonan,bluebird bio公司的董事和10%的股东,于06/20/2024提交了一份初始证券受益所有权声明书给美国证券交易委员会(SEC)。这份文件是证券交易法(1934年)第16(a)条的要求,表明Cloonan并没有持有公司的任何非衍生或衍生证券。该表格由Sydney Gaylin代表Cloonan于06/24/2024签署,确认报告人的受益所有权状况,并是某些公开交易公司内特定职位人员的标准板程序。
Michael Cloonan,bluebird bio公司的董事和10%的股东,于06/20/2024提交了一份初始证券受益所有权声明书给美国证券交易委员会(SEC)。这份文件是证券交易法(1934年)第16(a)条的要求,表明Cloonan并没有持有公司的任何非衍生或衍生证券。该表格由Sydney Gaylin代表Cloonan于06/24/2024签署,确认报告人的受益所有权状况,并是某些公开交易公司内特定职位人员的标准板程序。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息